EPA's CCL 6 Explained: How the Drinking Water Watch List Becomes Regulation

When the EPA published its draft Sixth Contaminant Candidate List (CCL 6) on April 2, 2026, the agency added microplastics and pharmaceuticals to the federal drinking water watch list for the first time, alongside PFAS, disinfection byproducts, 75 individual chemicals, and 9 microbes. Headlines treated the announcement as a regulatory action. It is not. The CCL is the front end of a pipeline that, over its three-decade history, has produced exactly one set of enforceable drinking water limits — the PFAS MCLs finalized in April 2024, 26 years after PFAS first appeared on CCL 1 in 1998. This guide explains what the CCL actually does, how the pipeline works, why it moves slowly, and what CCL 6 is likely to produce in practice.

What the CCL Is

The Contaminant Candidate List (CCL) is a formal EPA roster of drinking water contaminants that are not currently regulated under federal Safe Drinking Water Act standards but that the agency has identified as priorities for further evaluation. The list is required by the 1996 Safe Drinking Water Act amendments and must be updated every five years.

The CCL is fundamentally different from a Maximum Contaminant Level (MCL). An MCL is an enforceable limit that triggers utility compliance monitoring, reporting, and treatment obligations. A CCL listing is a research and monitoring designation — it identifies contaminants for further study and signals possible future regulation, but it does not require utilities to do anything new. No tests, no treatment changes, no reporting.

The distinction matters because press coverage often conflates the two. When the April 2026 announcement said “EPA adds microplastics to drinking water list,” the practical translation was: “EPA identifies microplastics as a research priority and may, after a multi-stage process taking many years, eventually propose enforceable limits.”

The Six CCLs to Date

Each CCL has built on its predecessors. Contaminants generally remain on subsequent CCLs unless the EPA makes a regulatory determination — a formal yes or no decision — about whether to regulate them.

The expansion of group-level listings — PFAS as a class on CCL 5, then microplastics, pharmaceuticals, and disinfection byproducts as classes on CCL 6 — is the most consequential structural change in the program’s history. Group listings reflect the recognition that some contamination problems involve thousands of chemically related compounds with shared exposure pathways, and that regulating them one molecule at a time is impractical.

How a Contaminant Moves From CCL to MCL

The pipeline from CCL listing to enforceable drinking water standard has four stages. Each stage takes years, and contaminants can stall or exit at any point.

Stage 1: CCL Listing (Where We Are for Most CCL 6 Entries)

The EPA evaluates nominated contaminants against statutory criteria and adds them to the CCL. The agency must consider whether the contaminant may have adverse health effects, whether it occurs or is likely to occur in public water systems at levels of public health concern, and whether regulating it would present a meaningful opportunity for public health protection. The CCL is published in the Federal Register, opened for public comment, reviewed by the EPA Science Advisory Board, and finalized.

For CCL 6, public comment closes June 5, 2026. The Science Advisory Board review and finalization is targeted for November 17, 2026.

Stage 2: Unregulated Contaminant Monitoring Rule (UCMR)

For contaminants where the EPA needs nationwide occurrence data, the agency adds them to the next Unregulated Contaminant Monitoring Rule (UCMR). UCMRs run on five-year cycles and require all public water systems above a defined size threshold to test for the listed contaminants over a defined sampling window.

UCMR 5 (2023–2025) monitored 30 contaminants — 29 PFAS compounds and lithium. UCMR 6 is being developed for 2028–2030 implementation, and the contaminants selected will determine what nationwide occurrence data exists for future regulatory decisions. Critically: a contaminant cannot be regulated through to an MCL without occurrence data, and occurrence data for chemicals not yet detectable by an EPA-approved analytical method cannot be collected.

This is the structural barrier facing microplastics. There is no EPA-approved standard analytical method for measuring microplastics in drinking water, which means microplastics cannot enter UCMR 6 at the same level as PFAS or lithium did UCMR 5 — even though they sit on CCL 6. Method development is itself a multi-year project.

Stage 3: Regulatory Determination

After occurrence data is collected, the EPA issues a regulatory determination — a formal yes-or-no decision on whether to regulate. The agency must make a positive determination on at least five contaminants from each CCL, and must issue determinations within statutory deadlines.

A positive determination requires the EPA to find all three of the following:

1. The contaminant may have adverse health effects
2. The contaminant occurs or is likely to occur at levels of public health concern
3. Regulation presents a meaningful opportunity for public health protection

A negative determination ends the regulatory pipeline for that contaminant — it remains on the CCL but does not advance to rulemaking. Negative determinations are common. The EPA’s CCL 5 regulatory determinations, published just two weeks before CCL 6, declined to regulate all nine contaminants the agency evaluated, including microcystins and cylindrospermopsin — toxins associated with harmful algal blooms that have driven local drinking water emergencies.

Stage 4: Rulemaking and the MCL

A positive determination triggers a formal rulemaking. The EPA proposes a Maximum Contaminant Level Goal (MCLG), the non-enforceable health-protective target, and a Maximum Contaminant Level (MCL), the enforceable standard set “as close to the MCLG as feasible” considering treatment technology and cost. The rule goes through proposal, public comment, and finalization — typically a 2–3 year process minimum.

After finalization, utilities receive a compliance window (typically 3–5 years) before enforcement begins. The PFAS MCLs finalized April 2024 carried compliance deadlines in 2029 — extended by the current administration to 2031 for PFOA and PFOS and rescinded entirely for four other PFAS.

What’s on Draft CCL 6

The April 2026 draft CCL 6 is the largest list to date.

Several of the individual chemicals reflect contaminants WaterVerge has covered in depth. Hormones (estrone, ethinylestradiol, equilin) appear individually even as the broader pharmaceutical group is also listed. Manganese, vanadium, and several other metals appear despite being detected nationwide in UCMR cycles — reflecting the pipeline’s slowness even for well-characterized contaminants. The microbe list elevates Legionella and Mycobacterium avium complex among other waterborne pathogens.

Alongside the CCL 6 publication, the EPA released human health benchmarks for 374 individual pharmaceutical compounds — screening values utilities and states can use to evaluate the risk of detected drug residues. The HHS simultaneously announced a $144 million Systematic Targeting of MicroPlastics (STOMP) initiative to study microplastic accumulation and effects in human biology. These parallel announcements indicate the EPA is investing in the underlying science even as it acknowledges that formal regulation is years away.

Why the Process Moves So Slowly

The CCL pipeline takes decades because each stage is constrained by science, statute, and politics.

Science. Establishing health benchmarks requires toxicology data sufficient to derive a defensible reference dose, adjusting for sensitive populations and uncertainty. For emerging contaminants without long exposure histories, the data simply does not exist at first listing. Generating it takes years of academic and federal research.

Analytical methods. Occurrence monitoring requires an EPA-approved standard method for detection — a procedure laboratories nationwide can implement consistently to produce comparable results. Developing, validating, and approving a method for a new contaminant typically takes 3–5 years.

Statute. The Safe Drinking Water Act requires the EPA to consider treatment feasibility and cost when setting the enforceable MCL. The agency cannot set an MCL substantially lower than what well-operated treatment plants can reliably achieve, even if a lower number would be more health-protective. The MCLG (the health goal, often zero) and the MCL (the enforceable limit) frequently differ for this reason.

Politics. Each administration brings its own pace. PFAS regulation accelerated under the Biden administration, with the first-ever PFAS MCLs finalized in April 2024. The current administration has proposed rolling back four of those PFAS limits and extending compliance deadlines for the remaining two. The pace of CCL 6 advancement will depend on administrative priorities; the formal listing in April 2026 does not commit any particular timeline for further action.

What CCL 6 Likely Means in Practice

Realistic projections, based on historical CCL pipeline performance:

The honest summary is that CCL 6 is a research and signaling exercise. It identifies priorities, mobilizes federal investment, and signals to filtration manufacturers and state regulators that certain contaminants are on the federal radar. It does not create immediate utility obligations, and most contaminants on the list will not receive enforceable federal limits within the next decade.

How Filtration Stays Ahead of Regulation

A consistent pattern across the CCL’s history is that household filtration technology runs years to decades ahead of federal regulation. By the time PFAS MCLs were finalized in 2024, NSF/ANSI 53 and 58 certified filters had been removing PFOA and PFOS at high efficiency for years. The same pattern is already apparent for CCL 6 contaminants:

• Reverse osmosis systems remove pharmaceuticals, microplastics, and most PFAS compounds at high efficiency. See our guide to the best reverse osmosis systems for current NSF-certified options.
• NSF/ANSI 401 certified filters are specifically tested against 15 emerging contaminants including pharmaceuticals (ibuprofen, naproxen, estrone, atenolol, carbamazepine, trimethoprim) and certain detergent metabolites. Several pitcher and faucet-mount filters carry this certification.
• Activated carbon filters with adequate contact time and replacement schedules reduce many pharmaceutical residues, though the removal rate varies sharply by compound.

The implication for households is that you do not need to wait for federal regulation to address CCL 6 contaminants in your own water. The filtration technology exists today.

How to Use This Knowledge

Read your CCR with regulatory context in mind. Your annual Consumer Confidence Report covers regulated contaminants. If a CCL 6 contaminant matters to you — pharmaceuticals if you have an immunocompromised household, microplastics if you have infants, Legionella if you live in a multi-unit building or work in a hospital — your CCR will not reflect it. See our guide to reading your CCR for what’s covered and what isn’t.

Test independently if you have a specific concern. For most CCL 6 contaminants, the only way to obtain data for your specific tap is independent testing through a certified lab. Pharmaceutical screening costs roughly $250–$600. Microplastic testing costs $150–$400. PFAS testing costs $250–$600. See our guide to testing your tap water for finding certified labs.

Filter for the contaminant class, not the specific compound. Reverse osmosis addresses essentially the entire CCL 6 chemical-group landscape — PFAS, pharmaceuticals, microplastics, and most disinfection byproducts. NSF/ANSI 401 certification is a more targeted signal for emerging contaminants if you do not need or want a full RO system.

Engage at the public comment stage. The CCL 6 public comment period closes June 5, 2026. Comments can be submitted at regulations.gov under docket EPA-HQ-OW-2024-0581. Comments from individuals, scientists, water utilities, and advocacy organizations all become part of the formal record EPA considers before finalizing the list.

Frequently Asked Questions

Is CCL 6 a new drinking water rule?

No. The CCL is a watch list. It identifies contaminants the EPA is studying for possible future regulation. It does not require utilities to test for, treat, or report on listed contaminants. New federal drinking water rules require a separate multi-stage rulemaking process that, historically, takes a decade or more after CCL listing.

When will microplastics be regulated?

Almost certainly not in this decade. Microplastics cannot be added to a UCMR until the EPA approves a standard analytical method, which is itself a multi-year project. Without nationwide monitoring data, the EPA cannot make a positive regulatory determination. The most likely earliest scenario is method approval by the late 2020s, UCMR monitoring in the early 2030s, and an MCL in the mid-to-late 2030s if the science supports one.

What’s the difference between CCL 6 and UCMR 6?

The CCL identifies contaminants for further study. The UCMR requires utilities to actually test for a specific subset of contaminants over a defined monitoring window. The CCL is the watch list; the UCMR is the actual nationwide testing program. Contaminants typically appear on a CCL before they appear on a UCMR.

Why don’t CCL contaminants always become regulated?

Most don’t. The EPA must make positive findings on three statutory criteria — adverse health effects, occurrence at levels of public health concern, and meaningful opportunity for protection — before regulation can proceed. CCL 5 declined to regulate all nine contaminants evaluated. The CCL is a research priority designation, not a regulatory commitment.

Can I submit a public comment on CCL 6?

Yes. The 60-day comment period closes June 5, 2026. Submit comments at regulations.gov under docket EPA-HQ-OW-2024-0581. The Federal Register notice published April 6, 2026 contains submission instructions. Comments from individuals, technical experts, and organizations are all considered.

Check Your City

CCL 6 contaminants are not yet part of the regulated dataset that drives WaterVerge city-level grading. Our city pages show data on EPA-regulated contaminants — lead, PFAS MCL compliance, disinfection byproducts, nitrate, and others — sourced from SDWIS violations, UCMR results, and the Envirofacts LCR API.

Search your city to see your utility’s current regulated contaminant profile. As CCL 6 contaminants advance through UCMR cycles into formal regulation, we will integrate that data into city-level coverage. For now, the absence of federal monitoring means independent testing is the only way to obtain pharmaceutical, microplastic, or unregulated PFAS data for a specific tap.